Comparing TransEnterix (TRXDW) and Its Competitors

Insider & Institutional Ownership

8.2% of TransEnterix shares are owned by institutional investors. Comparatively, 22.5% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are owned by institutional investors. 3.1% of TransEnterix shares are owned by company insiders. Comparatively, 18.4% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Volatility & Risk

TransEnterix has a beta of 2.56, meaning that its stock price is 156% more volatile than the S&P 500. Comparatively, TransEnterix’s competitors have a beta of 1.76, meaning that their average stock price is 76% more volatile than the S&P 500.

Profitability

This table compares TransEnterix and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
TransEnterix	-2,149.15%	-83.74%	-64.94%
TransEnterix Competitors	-672.41%	-133.75%	-59.01%

Earnings and Valuation

This table compares TransEnterix and its competitors gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
TransEnterix	$8.53 million	-$154.20 million	-0.04
TransEnterix Competitors	$58.68 million	-$32.15 million	4.23

TransEnterix’s competitors have higher revenue and earnings than TransEnterix. TransEnterix is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

TransEnterix competitors beat TransEnterix on 7 of the 9 factors compared.

TransEnterix Company Profile

TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It also develops SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform.. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.